Effects of CDC7 gene silencing and Rituximab on apoptosis in diffuse large B cell lymphoma cells

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 12, 2012, Pages 2027-2034

  Hou, Yun ^a,b,c   Wang, Hua Qing ^a,b,c   Ba, Yi ^a,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Sino US Center for Lymphoma and Leukemia   (China)

^c KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Apoptosis; CDC7; DLBCL; PMCM2; Rituximab; SiRNA

Indexed keywords

CASPASE 3; CELL CYCLE PROTEIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; RITUXIMAB;

APOPTOSIS; ARTICLE; CDC7 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DOWN-REGULATION; GENE SILENCING; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; UP-REGULATION;

EID: 84871283266     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1283-2     Document Type: Article

References (20)

1. Alas S, Bonavida B (2001) Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non- Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 61:5137-5144
2. Chu PG, Loera S, Huang Q, Weiss LM (2006) Lineage determination of CD20- B-cell neoplasms: an immunohistochemical study. Am J Clin Pathol 126:534-544
3. Cossman J, Tsujimoto Y, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443
4. Cragg MS, French RR, Glennie MJ (1999) Signaling antibodies in cancer therapy. Curr Opin Immunol 11:541-547
5. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205-219
6. Deans JP, Schieven GL, Shu GL et al (1993) Association of tyrosine and serine kinases with B cell surface antigen CD20. J Immunol 151:4494-4504
7. Farnebo M, Bykov VJ, Wiman KG (2010) The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun 396:85-89
8. Fisher RI, Shah P (2003) Current trends in large cell lymphoma. Leukemia 17(10):948-1960
9. Goping IS, Gross A, Lavoie JN et al (1998) Regulated targeting of BAX to mitochondria. J Cell Biol 143:207-215
10. Hernandez-Ilizaliturri FJ, Jupudy V, Oflazoglu E et al (2003) Neutrophils contribute to the biological anti-tumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency (SCID) mouse model. Clin Cancer Res 9:5866-5873
11. Im JS, Lee JK (2008) ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7. J Biol Chem 283:25171-25177
12. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Tumors of haematopoietic and lymphoid tissue. IARC Press, Lyon
13. Jazirehi AR, Vega MI, Chatterjee D, Goodglick L, Bonavida B (2004) Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, BclxL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Cancer Res 64:7117-7126
14. Krawczyk J, Egan C, Mulvihill M et al (2009) Increased activity of the S phase kinase Cdc7 is associated with poor outcome in diffuse large B cell lymphoma (DLBCL) [abstract]. Blood (ASH Annual Meeting Abstracts) 114:Abstract nr 1914
15. Leist M, Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589-598
16. Montagnoli A, Moll J, Colotta F (2010) Targeting cell division cycle 7 kinase: a new approach for cancer therapy. Clin Cancer Res 16(18):4503-4508. Epub 2010 Jul 20. Review
17. Rosenwald A, Wright G, Chan WC et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large- B-cell lymphoma. New Engl J Med 346(25):1937-1947
18. Shan D, Ledbetter JA, Press OW (1998) Apoptosis of malignant human B cell by ligation of CD20 with monoclonal antibodies. Blood 91:1644-1652
19. Wei MC, Zong WX, Cheng EH et al (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730
20. Yun H, Hua-qing W, Yi B (2012) High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma. Med Oncol [Epub ahead of print]